Significance of serum concentrations of E-selectin and CA19-9 in the prognosis of colorectal cancer

Japanese Journal of Clinical Oncology

Volumn 40, Issue 11, 2010, Pages 1073-1080

  Sato, Harunobu ^a   Usuda, Nobuteru ^a   Kuroda, Makoto ^a   Hashimoto, Shuji ^a   Maruta, Morito ^a   Maeda, Koutarou ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CA19 9; Colorectal cancer; E selectin; Metastasis; Prognosis

Indexed keywords

BIOLOGICAL MARKER; CA 19-9 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ASSESSMENT; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALIDITY; PREOPERATIVE EVALUATION; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; E-SELECTIN; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 78049440004     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyq095     Document Type: Article

References (38)

1. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MJ. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987;84:9238-42.
2. Kannagi R, Fukushi Y, Tachikawa T, Noda A, Shin S, Shigeta K, et al. Quantitative and qualitative characterization of cancer-associated serum glycoprotein antigens expressing fucosyl or sialosyl-fucosyl type 2 chain polylactosamine. Cancer Res 1986;46:2619-26.
3. Koprowski H, Steplewski Z, Michell K. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 1979;5:957-62.
4. Mineo TC, Ambrogi V, Tonini G, Bollero P, Roselli M, Mineo D, et al. Long-term results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg 2003;197:386-91.
5. Diez M, Cerdan FJ, Pollan M, Ortega MD, Martinez S, Moreno G, et al. Prognostic significance of preoperative serum CA19-9 assay in patients with colorectal carcinoma. Anticancer Res 1994;14:2819-25.
6. Ueda T, Etsuji S, Urakawa T. The clinicopathologic features of serum CA19-9 positive colorectal cancers. Surg Today 1994;24:518-25.
7. Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R. Multivariate analysis of the prognostic value of CEA and CA19-9 serum levels in colorectal cancer. Anticancer Res 2000;20:5195-8.
8. Chen CC, Yang SH, Lin JK, Lin TC, Chen WS, Jiang JK, et al. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? J Surg Res 2005;124:169-74.
9. Sato T, Nishimura G, Nonomura A, Miwa K, Miyazaki I. Serological studies on CEA, CA19-9, STn and SLX in colorectal cancer. Hepatogastroenterology 1999;46:914-9.
10. Nozoe T, Rikimaru T, Mori E, Okuyama T, Takahashi I. Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma. J Surg Oncol 2006;94:132-7.
11. Filella X, Molina R, Grau JJ, Pique JM, Garcia-Valdecasas JC, Astudillo E, et al. Prognostic value of CA19-9 levels in colorectal cancer. Ann Surg 1992;216:55-9.
12. Forones NM, Tanaka M. CEA and CA19-9 as prognostic indexes in colorectal cancer. Hepatogastroenterology 1999;46:905-8.
13. Franchi F, pastore C, Izzo P, Calio E. CA19-9 in the monitoring of colorectal cancer after surgery. Med Oncol 2001;18:237-8.
14. Holubec L, Topolcan O, Pikner R, Pecen L, Vaclavickova J, Wirthova M, et al. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence. Anticancer Res 2000;20:5237-44.
15. Spila A, Ferroni P, Cosimelli M, D'Alessandro R, Abbolito MR, Mariotti S, et al. Comparative analysis of CA242 and CA19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation. Anticancer Res 2001;21:1263-70.
16. Griesenberg D, Nurnberg R, Bahlo M, Klapdor R. CEA, TPS, CA19-9 and CA72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Anticancer Res 1999;19:2443-50.
17. Plebani M, De Paoli M, Basso D, Roveroni G, Giacomini A, Galeotti F, et al. Serum tumor markers in colorectal cancer staging, grading, and follow-up. J Surg Oncol 1996;62:239-44.
18. Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sosaki Y, et al. Increased expression of sialyl Lewis X antigen is correlated with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study. Cancer Res 1993;53:3632-7.
19. Banks RE, Gearing AJH, Hemingway IK, Norfolk DR, Perren TJ, et al. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 1993;68:122-4.
20. Velikova G, Banks RE, Gearing A, Hemingway I, Forbes MA, Preston SR et al. Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer. Br J Cancer 1997;76:1398-404.
21. Hebbar M, Revillion F, Louchez MM, Vilain MO, Fournier C, Bonneterre J, et al. The relationship between concentrations of circulating soluble E-selectin and clinical, pathological and biological features in patients with breast cancer. Clin Cancer Res 1998;4:373-80.
22. Zhang GJ, Adachi I. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlations with clinicopathological features and progress. Int J Oncol 1999;14: 71-7.
23. Japanese society for cancer of the colon and rectum. Japanese Classification of Colorectal Carcinoma. 1st English edn. Tokyo: Kanehara & Co. 1997.
24. Japanese society for cancer of the colon and rectum. JSCCR Guidelines 2009 for the Treatment of Colorectal Cancer. 1st edn. Tokyo: Kanehara & Co. 2009.
25. Takada A, Ohmori K, Takahashi N, Tsuyuoka K, Yago A, Zenita K, et al. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis a1. Biochem Biophys Res Commun 1991;179:713-9.
26. Sawada R, Tsuboi S, Fukuda M. Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 1994;269: 1425-31.
27. Morita S, Nomura T, Fukushima Y, Morimoto T, Hiraoka N, Shibata N. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer? Dis Colon Rectum 2004;47:227-32.
28. Nakayama T, Watanabe M, Teramoto T, Kitajima M. CA19-9 as a predictor of recurrence in patients with colorectal cancer. J Surg Oncol 1997;66:238-43.
29. Tsumatori G, Ozeki Y, Takagi K, Ogata T, Tanaka S. Relation between the serum E-selectin level and the survival rate of patients with re-sected non-small cell lung cancers. Jpn J Cancer Res 1999; 90:301-7.
30. Uner A, Akcali Z, Unsal D. Serum levels of soluble E-selectin in colorectal cancer. Neoplasma 2004;51:269-74.
31. Ito K, Ye CL, Hibi K, Mitsuoka C, Kannagi R, Hidemura K, et al. Paired tumor marker of soluble E-selectin and its ligand sialyl Lewis A in colorectal cancer. J Gastroenterol 2001;36:823-9.
32. Takahashi Y, Mai M, Watanabe M, Tokiwa M, Nishioka K. Relationship between serum ELAM-1 and metastasis among patients with colon cancer. Dis Colon Rectum 1998;41:770-4.
33. Alexiou D, Karayiannakis AJ, Syrigos KN, Zbar A, Kremmyda A, Bramis I, et al. Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathologic features, patient survival and tumor surgery. Eur J Cancer 2001;37:2392-7.
34. Kitagawa T, Matsumoto K, Iriyama K. Serum cell adhesion molecules in patients with colorectal cancer. Surg Today 1998;28:262-7.
35. Matsumoto S. Cimetidine and survival with colorectal cancer. Lancet 1995;346:115.
36. Adams WJ, Morris DL. Short-course cimetidine and survival with colorectal cancer. Lancet 1994;344:1768-9.
37. Svendsen LB, Ross C, Knigge U, Frederiksen HJ, Graversen P, Kjaergard J, et al. Cimetidine as an adjuvant treatment in colorectal cancer. Dis Colon Rectum 1995;38:514-8.
38. Kobayashi K, Matsumoto S, Morishima T, Kawabe T, Okamoto T. Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 2000;60:3978-84.